![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 46, 32543-32546, November 12, 1999
§,
,
From the Institute of Pathology, Case Western Reserve University,
Cleveland, Ohio 44106, the ¶ Department of Biochemistry, Michigan
State University, East Lansing, Michigan 48824, and the
Department of Cell Biology, Cleveland Clinic Foundation,
Cleveland, Ohio 44195
| |
ABSTRACT |
|---|
|
|
|---|
Presenilin-1 (PS-1) is the most causative
Alzheimer gene product, and its function is not well understood. In an
attempt to elucidate the function of PS-1, we screened a human brain
cDNA library for PS-1-interacting proteins using the yeast
two-hybrid system and isolated a novel protein containing a
PSD-95/Dlg/ZO-1 (PDZ)-like domain. This novel PS-1-associated protein
(PSAP) shares a significant similarity with a Caenorhabditis
elegans protein of unknown function. Northern blot analysis
revealed that PSAP is predominantly expressed in the brain. Deletion of
the first four C-terminal amino acid residues of PS-1, which contain
the PDZ domain-binding motif (Gln-Phe-Tyr-Ile), reduced the binding activity of PS-1 toward PSAP 4-fold. These data suggest that PS-1 may
associate with a PDZ-like domain-containing protein in vivo and thus may participate in receptor or channel clustering and intracellular signaling events in the brain.
To date, familial forms of Alzheimer's disease have been linked
to mutations in three different genes. The first is the amyloid precursor protein (APP)1 gene
located on chromosome 21 (1). The other two genes are presenilin-1
(PS-1) and presenilin-2 (PS-2), located on chromosomes 14 and 1, respectively (2, 3). Mutations in all three genes lead to either
increased total amounts of amyloid On the basis of the predicted multiple transmembrane structure, it has
been suggested that presenilin proteins may function as signal
receptors, form channels, or participate in protein trafficking (2).
Evidence supporting a signaling function for PS-1 and PS-2 comes from
studies showing that both wild-type PS-1 and PS-2 cDNAs can
complement Sel-12, a Caenorhabditis elegans homologue
of PS-1 (PS-2), which facilitates Notch/Lin-12 signaling and cell fate
specification during development (5). The involvement of PS-1 in
Notch-mediated signaling during mammalian embryogenesis has also been
suggested by studies using knockout mice (6, 7). Furthermore, mutations
in PS-1 and PS-2 have been implicated in apoptotic cell death (8, 9).
Protein topological studies suggest that PS-1 and PS-2 proteins have
six to eight transmembrane domains (2, 10-12). Despite the diversity,
it is notable that in all the topological models, the C-terminal domain
is oriented toward the cytoplasm. This suggests that the C-terminal
domain might mediate protein-protein interactions. Furthermore, it has been shown that the C-terminal fragment of PS-2 functions as a dominant
negative mutant in T-cell receptor-induced apoptosis (8). This role
might be explained by competitive binding of the C-terminal fragment to
an unknown factor, resulting in the inhibition of signal transduction
mediated by PS-2.
We have used the C-terminal fragment of PS-1 as a probe to screen a
human brain cDNA library for PS-1-interacting protein(s). In this
report, we describe the molecular cloning and characterization of a
novel molecule, PSAP (PS-1-associated
protein), which interacts with the C terminus of PS-1.
Sequence analysis revealed that PSAP contains several putative protein
kinase C and tyrosine kinase phosphorylation sites and shares a
significant similarity with a C. elegans protein of unknown
function. Interestingly, it was also found that PSAP contains a PDZ
domain-like structure, which may account for its binding to the
C-terminal Phe-Tyr-Ile-COOH motif of PS-1, a consensus sequence of the
PDZ domain-binding site.
Yeast Two-hybrid and cDNA Library Screening--
All yeast
strains, plasmids, and the human brain cDNA library used in the
two-hybrid experiments were from CLONTECH as
components of the Matchmaker two-hybrid system. The C-terminal 79 amino
acids of PS-1 (PS1C79) were fused to the GAL4 DNA binding domain by subcloning the polymerase chain reaction-amplified corresponding coding
region into the pAS2-1 vector (pAS1C79). Yeast strain Y190 was
co-transformed with the plasmid pAS1C79 and a human brain cDNA
library fused to the GAL4 transcription activation domain in pACT2
vector. Two-hybrid screening was carried out according to the
manufacturer's instructions (CLONTECH).
Galactosidase Assays--
The following plasmids were used in
yeast mating experiments. Blank vectors pAS2-1 and pACT2, pVA3-1 (p53
gene in pAS2-1), pTD1-1 (SV40 large T antigen in pACT2), and pLAM5'-1
(the lamin C gene in pAS2-1) from CLONTECH were
used as controls. Plasmid pACPSAP was isolated from one of the two
positive clones. The pAS1C79 plasmid was constructed as described
above. Plasmids pAS1Loop (amino acids 302-376 of PS-1), pAS1HP(7-8)
(amino acids 263-407 of PS-1), deletion mutant pAS1C79( Immunoprecipitation and Western Blot--
PS-1 with an
N-terminal FLAG tag was subcloned into pCEP4. PSAP tagged with a Myc
tag at the C terminus was subcloned into pCDNA3.1. HEK293 cells
were stably transfected with a PSAP-expressing vector. To determine the
interaction of PSAP with PS-1 in intact cells, cells stably expressing
PSAP were further transiently transfected with PS-1 expression vector.
The total cell lysate for immunoprecipitation was obtained as
18,000 × g supernatant after cell lysis in lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl,
0.5% Triton X-100, 5 mM EDTA) containing protease
inhibitors on ice for 30 min. The supernatants were incubated with
Northern Blot Analysis--
Multiple tissue Northern blot
(CLONTECH) containing 2 µg of poly(A)+ mRNA
isolated from a variety of human tissues was probed with the 1.2-kb
cDNA corresponding to the PSAP coding region. Northern
hybridization was performed according to the manufacturer's instructions (CLONTECH). The blot was also probed
with radiolabeled PS-1 Interacts with a PDZ-like Domain-containing Protein--
Of
3.1 × 106 total clones screened using PS1C79 as a
probe, two positive clones, 46 and 299, were isolated. To eliminate
false positives, yeast-mating experiments were carried out. As shown in
Table I, only the transformant pair that
bears the bait plasmid pAS1C79 and the plasmid pACPSAP from clone
46, as well as the transformant pair that bears the positive control
plasmids containing murine p53 and SV40 large T, were positive for the
His3 phenotype and for
Restriction mapping and DNA sequencing analysis indicated that these
two clones are identical and contain a 1.9-kb cDNA. We have
performed the 5'-RACE (rapid amplification of cDNA ends) reaction
using human brain whole cDNA (CLONTECH), and no
DNA fragment with a 5'-end longer than the insert in the two positive
clones has been isolated. The putative open reading frame of 1113 base pairs encodes a polypeptide of 371 amino acids with a predicted mass of
39.9 kDa, designated as PSAP (Fig.
1A). Sequence analysis of PSAP
using "Prosite" revealed six consensus sites for phosphorylation by
protein kinase C, three by casein kinase II, one by
cAMP-dependent kinase, and one by tyrosine kinase (Fig.
1A). A BLAST search of GenBankTM revealed that
PSAP is novel but shares homology (28% identity, 65% similarity) with
a C. elegans protein, F43E2.7, of unknown function (14). It
was also found that PSAP contains a GLLGF sequence preceded by a basic
amino acid lysine that is similar to the conserved motif,
R(K)XXXXXGLGF, found in most PDZ proteins and as seen in the
binding pocket of a typical PDZ protein, PSD-95 (15). The overall
homology between the PDZ-like domain (amino acids 222-304) of PSAP and
typical PDZ domains is lower but significant, 12-14% identical in
80-95 amino acids (Fig. 1B). PSAP, like the Vesl/Homer
family protein (16, 17), may represent another unique member of the PDZ
protein super-family.
PS1C79 Interacts with PSAP in a Specific Manner--
To determine
the specificity of the interaction of PS1C79 with PSAP, we tested
whether other fragments of PS-1, including the large loop between the
sixth and seventh transmembrane domains, interact with PSAP in the
yeast two-hybrid system. As shown in Table I, none of the tested
fragments interacts with PSAP. The finding that the fragment HP(7-8),
which contains two hydrophobic regions flanking the large hydrophilic
loop, failed to interact with PSAP indicates that the interaction
between PS1C79 and PSAP is specific and not due to the hydrophobic
binding. The direct and specific interaction between PS1C79 and PSAP
was also confirmed by an in vitro binding assay using a
glutathione S-transferase-PS fusion protein and a
35S-labeled PSAP
protein.2 We also tested
whether the C-terminal 79-residue region of PS-2, which is highly
conserved between PS-1 and PS-2, interacts with PSAP. As shown in Table
I, PS2C79 failed to interact with PSAP in the yeast two-hybrid assay.
PSAP Interacts with Full-length PS-1 in Intact Cells--
HEK293
cells stably expressing Myc-tagged PSAP were transiently transfected
with plasmid encoding FLAG-tagged PS1. As a control, cells stably
expressing Myc-tagged LacZ were also transiently transfected with PS-1.
Twenty-eight hours later, cells were lysed and then
co-immunoprecipitated, and Western blot analysis was performed. As
shown in Fig. 2, PS-1 was specifically
co-immunoprecipitated with PSAP by anti-Myc antibody. This result
indicates that PSAP interacts with PS-1 in intact cells.
PS1C79-PSAP Interaction Requires the C-terminal
Gln-Phe-Tyr-Ile-COOH Motif of PS-1--
Ligand interaction studies
have revealed that PDZ domains bind to a consensus sequence in the C
terminus of the target protein, which contains a hydrophobic or an
aromatic amino acid as the last amino acid (18). On the basis of the
primary sequences, two large groups of unique C-terminal motifs of
target proteins are recognized by two PDZ domain classes. Class I PDZ
domain binds to a C-terminal motif with the sequence
Ser/Thr-X-Val/Ile-COOH. In contrast, class II PDZ domains
have a preference for Phe/Tyr-X-Phe/Val/Ale/?-COOH (18). We
examined PS-1 for this motif and found a sequence, Gln-Phe-Tyr-Ile-COOH, at the extreme C terminus of PS-1. The glutamine residue at the PSAP Is Expressed Predominantly in the Brain--
Expression of
PSAP mRNA in human tissues was examined by Northern blot analysis.
The PSAP cDNA was used to probe Northern blots containing poly(A)+
RNA from human tissues. A 1.9-kb mRNA was detected in all tissues
examined. The highest levels are observed in the brain, with lower
levels in the heart and barely detectable levels in other tissues (Fig.
4). The size of the PSAP mRNA
detected in Northern blots is consistent with the size of the PSAP
cDNA isolated using the two-hybrid system.
In the present study, we identified a novel protein, PSAP, that
interacts with the C terminus of PS-1 and contains a PDZ-like domain, a
motif thought to mediate protein-protein interactions and to be
involved in cellular junction formation, receptor or channel
clustering, and cellular signaling events. PS-1 has been implicated in
the Notch/Sel-12 signaling pathway; thus, the direct interaction of
PSAP with the C terminus of PS-1 may play a regulatory role in
PS-1-mediated Notch and/or wingless signal transduction by analogizing
the function of Dsh, which contains one PDZ domain and is required for
signal transduction from seven-transmembrane receptors, frizzled and
Dfz2, in the wingless signal pathway in Drosophila. (for
review see Ref. 19).
One of the important functions of PDZ domain-containing proteins is in
the clustering and localization of specific classes of ion channels at
synapses and possibly other sites of membrane specialization in
neurons. Recently, it has been reported that the overexpression of PS-1
and PS-2 up-regulates functional K+ channel expression
either by directly associating with K+ channel pore-forming
subunits or by indirectly increasing the synthesis, assembly, and/or
transport of these subunits to the plasma membrane (20). The mechanism
underlying the effects of presenilins on ion channels is not
understood. Studies employing cell culture systems or transgenic mice
have shown that Alzheimer mutant presenilins influence APP processing
in a manner that elevates production of the longer and more
amyloidogenic A In a recent study, we found that PS-1 has a regulatory effect on the
GTPase activity of Go and may function as a G
protein-coupled receptor (21). It is notable that about 30% of known G
protein-coupled receptors contain the PDZ-binding sequence (22). In
Drosophila, a PDZ domain-containing protein, InaD, serves as
a scaffold to assemble different signaling molecules of the
Gq-regulated phototransduction cascade (23). By analogy,
this implies a potential role for PSAP in the Go-regulated
signaling pathway mediated by PS-1.
PSAP contains only one PDZ-like domain and no other modular
domains such as Src homology 2 (SH2), SH3, or pleckstrin homology (PH).
However, PSAP contains several potential protein kinase phosphorylation
sites by various kinases. These phosphorylation sites may be important
for the regulation of the function of PSAP by the kinase activities
and/or important in mediating the interaction of PSAP with other molecules.
It is also noteworthy that PSAP specifically interacts with PS-1 but
not PS-2. This may be because of the substitution of Leu for Phe at
position In conclusion, we have identified a novel molecule, PSAP, a unique PDZ
domain-containing protein that specifically binds to PS-1. Mutational
analysis revealed that the C-terminal Gln-Phe-Tyr-Ile-COOH, motif of
PS-1 is required for the interaction with PSAP. PSAP is predominantly
expressed in the brain and may function as an adaptor molecule that
links PS-1 to an intracellular signal transduction pathway. This
finding may open a new avenue for determining the normal and
pathological functions of PS-1 and the mechanism by which PS-1 is
involved in Alzheimer's disease.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-peptide (A
) or longer (42-43
amino acids) and hence more amyloidogenic A
formation. This supports
the hypothesis that the aberrant processing of APP and the A
deposition are the primary pathogenic events in Alzheimer's disease
development (for review see Ref. 4). However, the mechanism by which
the mutant APP, PS-1, and PS-2 alter both APP processing and the normal
function of these proteins remains obscure.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
4), which
lacks the last C-terminal 4 amino acids of PS-1, and pAS2C79, which
contains the last 79 amino acids of PS-2, were also constructed in the
pAS2-1 vector. Plasmids based on the pAS2-1 vector were used to
transform the yeast strain Y187. Plasmids based on the pACT2 vector
were used to transform the yeast strain Y190. The mating experiments
and color development assays were performed according to the
manufacturer's instructions (CLONTECH). For
qualitative evaluation of the interaction between PS1C79 and PSAP,
galactosidase filter lift assays were performed. For quantitative
studies, galactosidase activity was determined using the
chemiluminescent Galacton-Star detection kit
(CLONTECH).
-Myc (Invitrogen) or AD3L or anti-L (specific to the C-terminal
fragment of PS-1 (10, 13)) and protein A-Sepharose overnight at
4 °C. The immunoprecipitates were separated by 10-16% Tris/glycine
SDS-PAGE and probed with the appropriate antibody. The blots were
visualized by ECL-Plus (Amersham Pharmacia Biotech).
-actin cDNA (CLONTECH) as
an indicator of RNA loading.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-galactosidase activity, indicating a true
positive interaction between PS1C79 and PSAP. Plasmid from clone 299 was also tested in the mating experiment, and the same results were
observed (data not shown).
Interaction of PSAP with PS1C79 in the yeast two-hybrid system

View larger version (52K):
[in a new window]
Fig. 1.
Sequence analysis of PSAP. A,
amino acid sequence of PSAP. Putative sites of phosphorylation by
protein kinase C are circled, those by casein kinase are
boxed, that by tyrosine kinase is shown in bold
underlined letters, and that by cAMP-dependent kinase
activity is shown in bold letters. B, amino acid
sequence alignment between the PDZ-like domains of PSAP and other PDZ
domain proteins. Residues identical to or similar to the PSAP sequence
are heavily shaded or lightly shaded,
respectively.

View larger version (43K):
[in a new window]
Fig. 2.
Interaction of PSAP and PS-1 in transfected
cells. Antibodies used for immunoprecipitation and for detection
are indicated on the top and the bottom of the
figure. Samples in lanes 1-4 were boiled in
reducing buffer. Samples in lanes 5-12 were
prepared in nonreducing buffer and unboiled. FLAG-tagged PS-1
(PS1) was specifically co-immunoprecipitated with PSAP from
cells co-transfected with both PSAP and PS-1 cDNA (lane
6). The bands labeled H and L in lanes
1-4 correspond to the heavy chain and light chain, respectively,
of the mouse anti-Myc antibody used for immunoprecipitation. These
bands were detected as large complexes in lanes
5-8 under nonreducing conditions. Because the antibody
AD3L, used for immunoprecipitation in lanes 9-12,
was raised from rabbit, no corresponding bands were detected by an
anti-mouse secondary antibody.
4 position was also shown to influence the interaction (18). To determine whether the sequence Gln-Phe-Tyr-Ile-COOH is the
PSAP-binding motif of PS-1, we deleted this sequence in PS1C79. This
mutant, PS1C79(
4), interacts poorly with PSAP and the binding
activity was reduced by 4-fold compared with native PS1C79 (Fig.
3 and Table I). This result indicates
that the sequence Gln-Phe-Tyr-Ile-COOH in PS-1 is required for optimal
interaction with PSAP.

View larger version (24K):
[in a new window]
Fig. 3.
Quantitative galactosidase assay. The
mating experiments were performed using the same plasmids as described
in Table I. Galactosidase activity was determined using the
chemiluminescent Galaton-Star detection kit. The values presented are
the average of three independent transformant assays.

View larger version (67K):
[in a new window]
Fig. 4.
Northern blot analysis of PSAP RNA. RNA
from various human tissues: Heart, Brain,
Placenta, Lung, Liver, skeletal (Sk.)
muscle, Kidney, and Pancreas, as
indicated. Upper panel, the blots were hybridized with a
probe generated from PSAP cDNA. Lower panel, the blot
was probed with radiolabeled
-actin cDNA as an indicator of RNA
loading.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(4). However, whether this aberrant A
production
results from the alteration of protein trafficking caused by mutant
presenilin remains to be established. By analogizing the function of
the known PDZ proteins, further investigation on the role of the direct
interaction between PSAP and PS-1 will provide important information on
these issues.
3 in PS-2. This result suggests that PS-1 and PS-2 may
be involved in different signaling pathways. The differences in the
physiological regulation and/or function of PS-1 and PS-2 were also
suggested by the observations that PS-1 and PS-2 possess different
phosphorylation patterns (24, 25).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Peter H. St. George-Hyslop (University of Toronto, Toronto, Canada) for providing the PS-1 and PS-2 cDNAs; Dr. Hiroshi Mori (Tokyo Institute of Psychiatry, Tokyo, Japan) and Dr. Gopal Thinakaran (The Johns Hopkins University, Baltimore, MD) for providing antibodies specific to the C terminus of PS-1; and Dr. Paul Copeland and Allison Winokur for critical reading of this manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Alzheimer's Association Grant PRG-98-006 and a pilot grant from Sigma Kappa (to X. X.), National Institutes of Health Grants NS-37869-01 (to X. X.), P50 AG08012 (to the Alzheimer Center at Case Western Reserve University), and AG08992 (to P. G.), and the Britton fund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF189289.
Current address: Dept. of Pathology, University of Tennessee, 2407 River Dr., Knoxville, TN 37996.
§ To whom correspondence should be addressed (see "Current address"). Tel.: 423-974-8206; Fax: 423-974-5616; E-mail: xmx@utk.edu.
2 X. Xu, Y.-c. Shi, X. Wu, P. Gambetti, D. Sui, and M.-Z. Cui, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
APP, amyloid
precursor protein;
A
, amyloid
-peptide;
PS, presenilin;
PSAP, PS-1-associated protein;
PDZ, PSD-95/Dlg/ZO-1;
kb, kilobase pair.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) Nature 325, 733-736[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., and Montesi, M. P. (1995) Nature 375, 754-760[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Levy-Lahad, E.,
Wasco, W.,
Poorkaj, P.,
Romano, D. M.,
Oshima, J.,
Pettingell, W. H., Yu, C. E.,
Jondro, P. D.,
Schmidt, S. D.,
Wang, K.,
Crowley, A. C.,
Fu, Y.-H.,
Guanetta, S. Y.,
Galas, D.,
and Nemens, E.
(1995)
Science
269,
973-977 |
| 4. |
Selkoe, D. J.
(1997)
Science
275,
630-631 |
| 5. | Levitan, D., and Greenwald, I. (1995) Nature 377, 351-354[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H., and Sisodia, S. S. (1997) Nature 387, 288-292[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., and Tonegawa, S. (1997) Cell 89, 629-639[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Vito, P.,
Ghayur, T.,
and D'Adamio, L.
(1997)
J. Biol. Chem.
272,
28315-28320 |
| 9. |
Guo, Q.,
Sopher, B. L.,
Furukawa, K.,
Pham, D. G.,
Robinson, N.,
Martin, G. M.,
and Mattson, M. P.
(1997)
J. Neurosci.
17,
4212-4222 |
| 10. | Doan, A., Thinakaran, G., Borchelt, D. R., Slunt, H. H., Ratovitsky, T., Podlisny, M., Selkoe, D. J., Seeger, M., Gandy, S. E., Price, D. L., and Sisodia, S. S. (1996) Neuron 17, 1023-1030[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Lehmann, S.,
Chiesa, R.,
and Harris, D. A.
(1997)
J. Biol. Chem.
272,
12047-12051 |
| 12. |
Dewji, N. N.,
and Singer, S. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14025-14030 |
| 13. | Yamamoto, A., Sahara, N., Usami, M., Okochi, M., Kondo, T., Kametani, F., Tanaka, K., Yahagi, Y., Shirasawa, T., Itoyama, Y., and Mori, H. (1996) Biochem. Biophys. Res. Commun. 226, 536-541[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., Coulson, A., Craxton, M., Dear, S., Du, Z., and Durbin, R. (1994) Nature 368, 32-38[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon, R. (1996) Cell 85, 1067-1076[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., and Worley, P. F. (1997) Nature 386, 284-288[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Kato, A.,
Ozawa, F.,
Saitoh, Y.,
Fukazawa, Y.,
Sugiyama, H.,
and Inokuchi, K.
(1998)
J. Biol. Chem.
273,
23969-23975 |
| 18. |
Songyang, Z.,
Fanning, A. S.,
Fu, C.,
Xu, J.,
Marfatia, S. M.,
Chishti, A. H.,
Crompton, A.,
Chan, A. C.,
Anderson, J. M.,
and Cantley, L. C.
(1997)
Science
275,
73-77 |
| 19. | Ponting, C. P., Phillips, C., Davies, K. E., and Blake, D. J. (1997) Bioessays 19, 469-479[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Malin, S. A., Guo, W.-X. A., Jafari, G., Goate, A. M., and Nerbonne, J. M. (1998) Neurobiol. Dis. 4, 398-409[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Smine, A.,
Xu, X.,
Nishiyama, K.,
Katada, T.,
Gambetti, P.,
Yadav, S. P.,
Wu, X.,
Shi, Y. C.,
Yasuhara, S.,
Homburger, V.,
and Okamoto, T.
(1998)
J. Biol. Chem.
273,
16281-16288 |
| 22. | Ranganathan, R., and Ross, E. M. (1997) Curr. Biol. 7, R770-R773[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Tsunoda, S., Sierralta, J., Sun, Y., Bodner, R., Suzuki, E., Becker, A., Socolich, M., and Zuker, C. S. (1997) Nature 388, 243-249[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Walter, J., Capell, A., Grunberg, J., Pesold, B., Schindzielorz, A., Prior, R., Podlisny, M. B., Fraser, P., Hyslop, P. S., Selkoe, D. J., and Haass, C. (1996) Mol. Med. 2, 673-691[Medline] [Order article via Infotrieve] |
| 25. |
Seeger, M.,
Nordstedt, C.,
Petanceska, S.,
Kovacs, D. M.,
Gouras, G. K.,
Hahne, S.,
Fraser, P.,
Levesque, L.,
Czernik, A. J.,
George-Hyslop, P. S.,
Sisodia, S. S.,
Thinakaran, G.,
Tanzi, R. E.,
Greengard, P.,
and Gandy, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5090-5094 |
This article has been cited by other articles:
![]() |
V. Lamarca, A. Sanz-Clemente, R. Perez-Pe, M. J. Martinez-Lorenzo, N. Halaihel, P. Muniesa, and J. A. Carrodeguas Two isoforms of PSAP/MTCH1 share two proapoptotic domains and multiple internal signals for import into the mitochondrial outer membrane Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1347 - C1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spasic, A. Tolia, K. Dillen, V. Baert, B. De Strooper, S. Vrijens, and W. Annaert Presenilin-1 Maintains a Nine-Transmembrane Topology throughout the Secretory Pathway J. Biol. Chem., September 8, 2006; 281(36): 26569 - 26577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8687 - 8697. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laudon, E. M. Hansson, K. Melen, A. Bergman, M. R. Farmery, B. Winblad, U. Lendahl, G. von Heijne, and J. Naslund A Nine-transmembrane Domain Topology for Presenilin 1 J. Biol. Chem., October 21, 2005; 280(42): 35352 - 35360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, R. Singh, P. Datta, Z. Zhang, C. Orr, Z. Lu, G. DuBois, A. S. Zervos, M. H. Meisler, S. M. Srinivasula, et al. The C-terminal Tail of Presenilin Regulates Omi/HtrA2 Protease Activity J. Biol. Chem., October 29, 2004; 279(44): 45844 - 45854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lamy, M. Ticchioni, A. K. Rouquette-Jazdanian, M. Samson, M. Deckert, A. H. Greenberg, and A. Bernard CD47 and the 19 kDa Interacting Protein-3 (BNIP3) in T Cell Apoptosis J. Biol. Chem., June 20, 2003; 278(26): 23915 - 23921. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Ni, H. Yuan, and G. Carpenter Role of the ErbB-4 Carboxyl Terminus in gamma -Secretase Cleavage J. Biol. Chem., February 7, 2003; 278(7): 4561 - 4565. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, Y.-c. Shi, W. Gao, G. Mao, G. Zhao, S. Agrawal, G. M. Chisolm, D. Sui, and M.-Z. Cui The Novel Presenilin-1-associated Protein Is a Proapoptotic Mitochondrial Protein J. Biol. Chem., December 6, 2002; 277(50): 48913 - 48922. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Selkoe Alzheimer's Disease: Genes, Proteins, and Therapy Physiol Rev, April 1, 2001; 81(2): 741 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanahashi and T. Tabira Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein Hum. Mol. Genet., September 1, 2000; 9(15): 2281 - 2289. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |